Genome Maintenance Systems in Cancer
Day 1 - Thursday 15 October, 2026
All times are in China Standard Time (CST, UTC+8)
| 8:40 a.m. | WELCOME REMARKS |
| Session Chairs: Heathcliff Dorado Garcia, Nature Cancer Qing Zhong, Shanghai Jiaotong University |
| 9:00 a.m. | Keynote Talk The Dance of Proteins and DNA in Nucleotide Excision Repair Wei Yang, National Institutes of Health (NIH), USA |
Session I: Frontiers in Genome Maintenance Mechanisms
| 10:00 a.m. | Role of PARG in DNA repair and genome maintenance Mitsuko Masutani, Nagasaki University, Japan |
| 10:25 a.m. | COFFEE BREAK |
| 10:45 a.m. | Humanizing Yeast Origin Recognition Complex for the Study of Human Diseases Bik Tye, Cornell University, USA |
| 11:10 a.m. | The genomic outcomes of DNA breakage and chromosome fragmentation Cheng-Zhong Zhang, Dana-Farber Cancer Institute and Harvard Medical School, USA |
| 11:35 a.m. | A homologous recombination repair trap drives synthetic lethality René Medema, Princess Máxima Center for Pediatric Oncology, The Netherlands |
| 12:00 p.m. | Short Talk A Noncanonical Role of MutLα in Replication Fork Stability and Cancer Therapy Xueying Li, Chinese Institute for Cancer Research, Chinese Institutes for Medical Research, Beijing |
| 12:15 p.m. | Session Panel |
| 12:30 p.m. | LUNCH |
Session II: Targeting DNA Replication and Repair Vulnerabilities
| Session Chairs: Gabrielle Brewer, Nature Reviews Cancer Cheng-Zhong Zhang, Dana-Farber Cancer Institute and Harvard Medical School |
| 1:45 p.m. | G Quadruplex–driven rewiring of homologous recombination modulates BRCAness Philipp Oberdoerffer, Johns Hopkins School of Medicine, USA |
| 2:10 p.m. | Replication Fork Stability and Cancer Ting Liu, Zhejiang University, China |
| 2:35 p.m. | Adventures with the PARPi, rucaparib: Back and forth between bench and bedside Nicola Curtin, Newcastle University, UK |
| 3:00 p.m. | Short Talk FANCM restrains structural genome evolution and creates a synthetic lethal vulnerability in BRCA1-deficient breast cancer Arvind Panday, Mayo Clinic |
| 3:15 p.m. | Session Panel |
| 3:30 p.m. | COFFEE BREAK |
Session III: DDR Defects and Synthetic Lethality
| Session Chairs: Safia Danovi, Nature Philipp Oberdoerffer, Johns Hopkins School of Medicine |
| 4:00 p.m. | SPOTting cell plasticity change in action Xin Lu, Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, UK |
| 4:25 p.m. | BRCAness Regulation by OFD1 and Centrosomal Cytoskeleton Dynamics Qing Zhong, Shanghai Jiaotong University School of Medicine, China |
| 4:50 p.m. | Targeting homologous recombination defective cancers Christopher Lord, The Institute of Cancer Research, UK |
| 5:15 p.m. | Session Panel |
| 5:30 p.m. | Short Talk Zinc Finger Proteins as Guardians of Genome Stability — Disease and Therapeutic Implications Thomas Clarke, Boston University Chobanian and Avedesian School of Medicine |
| 5:45 p.m. | Short Talk Beyond Repeat Expansion: Exploring the Mechanisms of WRN Synthetic Lethality in Microsatellite-Unstable Cancers Wei Wu, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences |
| 6:00 p.m. | Short Talk Intercellular DNA transfer mediated by migrasomes propagates genome instability Lin Deng, Shenzhen Bay Laboratory |
| 6:15 p.m. | End of day |
Day 2 - Friday 16 October, 2026
All times are in China Standard Time (CST, UTC+8)
| Session Chairs: Gabrielle Brewer, Nature Reviews Cancer Elaine Sanij, St Vincent’s Institute of Medical Research |
| 9:00 a.m. | Keynote Talk Innate Immune Sensing of Extrachromosomal DNA in Cancer Zhijian ‘James’ Chen, University of Texas Southwestern Medical Center, USA |
Session IV: Genomic Instability and Innate Immune Signaling
| 10:00 a.m. | A novel R-loop Binding Site in cGAS Balances Genome Surveillance and Immune Activation Li Lan, Duke University, USA |
| 10:25 a.m. | COFFEE BREAK |
| 10:55 a.m. | STING–TRPV2 Interplay: A Signaling Link Between Genome Maintenance, Calcium Dynamics, and Innate Immunity Zhongsheng You, Chinese Institutes for Medical Research, Beijing, China |
| 11:20 a.m. | DNAJA2 in genomic stability and innate immunity: more than a molecular chaperone Yaping Huang, Chinese Institutes for Medical Research, Beijing, China |
| 11:45 a.m. | Session Panel |
| 12:00 p.m. | Short Talk Three-dimension DNA assembly functions as potent and TREX1-resistant cGAS agonist Hailin Wang, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences |
| 12:15 p.m. | Short Talk A Human-Biased FXR–TRIM22–STAT1 Proteostatic Checkpoint Limits Radiation-Induced Antitumor Immunity Min Deng, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences |
| 12:30 p.m. | LUNCH |
Session V: DDR-targeted Combination Therapy
| Session Chairs: Kathryn McGinnis, Nature Progress Oncology Yaping Huang, CIMR |
| 1:45 p.m. | Targeting CHK1 in POLE-Mutant Colorectal Cancer: Synthetic Lethality and Enhanced PD-1 Blockade Feng Wang, Sun Yat-sen University Cancer Center, China |
| 2:10 p.m. | Molecular Classification for Precision Management in Patients with Esophageal Squamous Cell Carcinoma Zhihua Liu, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, China |
| 2:35 p.m. | The Opioid Growth Factor (OGF)-OGFR Pathway Suppresses Homologous Recombination (HR) by Inhibiting RAD51 Zhenkun Lou, Mayo Clinic, USA |
| 3:00 p.m. | Session Panel |
| 3:15 p.m. | Poster Session & COFFEE BREAK |
| 4:15 p.m. | A GAPDH–RPL13A translational checkpoint drives DNA repair failure after colorectal cancer surgery Huashan Liu, The Sixth Affiliated Hospital, Sun Yat-sen University, China |
| 4:40 p.m. | Short Talk Adaptive Recovery from Ascites-associated Osmotic Stress Reprograms the Ovarian Tumor Microenvironment and Potentiates Cancer Immunotherapy Youwei Zhang, Jinan University |
| 4:55 p.m. | Short Talk DDB2 Resolves Post Irradiation Transcription-Replication Conflicts to Determine Normal Tissue Sparing by FLASH Radiotherapy Youhang Li, Soochow University |
| 5:10 p.m. | Short Talk Clinically relevant ATR inhibition selectively disrupts joint molecule resolution in homology-directed DNA repair SHUNICHI TAKEDA, Shenzhen University |
| 5:25 p.m. | Meet-the-Editor Session |
| 6:00 p.m. | End of day |
Day 3 - Saturday 17 October, 2026
All times are in China Standard Time (CST, UTC+8)
Session VI: Resistance Mechanisms Associated with DDR Deficiency
| Session Chairs: Paraskevi Mallini, Nature Communications Li Lan, Duke University |
| 9:00 a.m. | Repairing broken chromosomes: Mechanistic insights from AlphaFold and cryo-EM Stephen West, The Francis Crick Institute, UK |
| 9:25 a.m. | Metabolic mediated DNA Repair Contributes to the Chemosensitivity in Cancer Jian Yuan, School of Medicine, Tongji University, China |
| 9:50 a.m. | Functional characterisation of nucleolar stress responses and rDNA genome stability Elaine Sanij, St Vincent’s Institute of Medical Research, Australia |
| 10:15 a.m. | COFFEE BREAK |
| 10:45 a.m. | Challenges and Opportunities in PARP-Based Cancer Therapy Shan Zha, Columbia University Irving Medical Center, USA |
| 11:10 a.m. | Panel Session |
| 11:25 a.m. | Short Talk WRNIP1 phase separation safeguards chromosome segregation and promotes tumor immune evasion Yijie Wang, Shandong Normal University |
| 11:35 a.m. | Short Talk Enhanced DNA damage repair and genotoxic resistance in the axolotl Ziyu Rong, Chinese Institute for Regenerative Biology and Medicine, Chinese Institutes for Medical Research, Beijing |
| 11:45 a.m. | Short Talk Redial 9-1-1 for replication stress: new insight into RAD9-HUS1-RAD1 (9-1-1) clamp complex Min Huang, School of Basic Medical Sciences, Shenzhen University Medical School |
| 11:55 a.m. | Short Talk Targeting Replication Fork Vulnerabilities with CX-5461 to Overcome PARP Inhibitor Resistance in High-Grade Serous Ovarian Cancer Ruofei Liu, St Vincent's Institute of Medical Research |
| 12:15 p.m. | CLOSING REMARKS |
Preliminary program – subject to change. Last updated: Oct 8, 2026.
Times are displayed in CST